Skip to search formSkip to main contentSkip to account menu

MSN/ALK Fusion Protein

Known as: MSN-ALK Fusion Protein, Moesin/ALK Tyrosine Kinase Receptor Fusion Protein 
A fusion protein encoded by the MSN/ALK fusion gene. This protein is comprised of most of the moesin protein, including the band 4.1 region, fused to… 
National Institutes of Health

Related topics

Related topics

3 relations
Fusion GeneMSN/ALK Fusion GeneTyrosine Phosphorylation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells
Abstract In the present study, we developed aptamer (Apt) conjugated mesoporous silica nanoparticles (MSNs) for specific delivery… 
Highly Cited
2016
Highly Cited
2016
Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging.
Highly Cited
2015
Highly Cited
2015
Report of the AMIA EHR-2020 Task Force on the status and future direction of EHRs
Over the last 5 years, stimulated by the changing healthcare environment and the Health Information Technology for Economic and… 
Highly Cited
2014
Highly Cited
2014
VEGF121-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) signaling cascade plays a critical role in tumor angiogenesis… 
Highly Cited
2014
Highly Cited
2014
Nanoassembles constructed from mesoporous silica nanoparticles and surface-coated multilayer polyelectrolytes for controlled drug delivery
Highly Cited
2013
Highly Cited
2013
Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
Highly Cited
2013
Highly Cited
2013
pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
Highly Cited
2013
Highly Cited
2013
Charge-reversal plug gate nanovalves on peptide-functionalized mesoporous silica nanoparticles for targeted drug delivery.
To develop a smart nanovalve on mesoporous silica nanoparticles (MSNs) for biomedical applications, a new type of peptide… 
Highly Cited
2008
Highly Cited
2008
Evaluation of Dimebon in cellular model of Huntington's disease
BackgroundDimebon is an antihistamine compound with a long history of clinical use in Russia. Recently, Dimebon has been proposed… 
2008
2008
A novel serine phosphorylation site detected in the n-terminal domain of estrogen receptor isolated from human breast cancer cells
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)